酸在心力衰竭中与保存的喷射分数:一个随机临床试验
Payman Zamani1, Sanjiv J Shah2, Jordana B Cohen1
1Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA cardiology
|December 18, 2024
概括
慢性无机酸盐补充剂并没有改善心力衰竭患者的运动耐受性,其中包括保留喷射分数 (HFpEF). 这项研究没有发现有氧能力或生活质量的显著益处.
科学领域:
- 心脏病学和运动生理学
- 心血管研究研究心血管研究
- 酸盐补充研究研究
背景情况:
- 氧化缺乏症与心力衰竭中的运动不耐受性有关,其中心力衰竭具有保存的喷射分数 (HFpEF).
- 之前的试点研究表明,无机酸盐对HFpEF的运动耐受性有潜在的益处.
研究的目的:
- 评估慢性无机酸盐给药对HFpEF患者更大的队列中运动耐受性的影响.
- 评估长期酸盐补充是否可以提高HFpEF的有氧能力和生活质量.
主要方法:
- 一个多中心,随机,双盲,交叉试验,涉及有症状的HFpEF患者.
- 参与者接受酸盐 (KNO3) 或化 (KCl) 治疗6周,1周的洗期.
- 主要终点包括氧气吸收峰值和心肺运动测试期间完成的总工作.
主要成果:
- 酸增加了血清氧化代谢物,但没有显著改善峰值氧气吸收或总工作.
- 在运动系统血管扩张储备或生活质量方面没有观察到显著的改善 (堪萨斯市心肌病问卷).
- 无机酸盐干预措施被参与者容忍得很好.
结论:
- 长期服用酸并没有提高HFpEF患者的有氧能力,运动表现或生活质量.
- 这些发现表明,无机酸盐补充剂可能不是一种有效的策略来改善该人口的运动不耐受性.
- 需要进一步的研究来探索HFpEF的替代治疗方法.
相关概念视频
Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Antihypertensive Drugs: Potassium-Sparing Diuretics
448
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
448
Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517


